PTP, a leading cloud consultancy firm specializing in the life sciences industry, is pleased to announce its partnership with TetraScience, the Scientific Data Cloud company and a pioneer in supporting customers in harmonizing scientific data. This partnership intends to optimise data-driven decision-making, speed up the drug discovery and development process, and ultimately enhance patient outcomes.
PTP has a proven track record of successfully guiding biotechnology companies through the complex landscape of pipeline workflows for drug discovery and development. PTP will provide services that enable biopharmaceutical companies to fully utilise their scientific data with TetraScience's cutting-edge scientific data cloud.
The Tetra Scientific Data Cloud(TM) provides the smooth integration of many data sources, giving scientific teams a uniform perspective of crucial data. Through this agreement, TetraScience's clients will be able to use PTP's clients' expertise in data gathering, centralization, and harmonisation to speed up decision-making, boost collaboration across interdisciplinary teams, and streamline workflows.
"We are thrilled to partner with TetraScience, a company that shares our passion for innovation and excellence in the life sciences industry," said Ethan Simmons, Managing Partner of PTP. "Their groundbreaking technology will enable us to provide unparalleled solutions to our clients, helping them make data-driven decisions and ultimately bring life-saving treatments to patients faster."
Chad Garrett, Chief Revenue Officer, TetraScience, said, "PTP's deep AWS and life sciences knowledge, along with commitment to client success make them an ideal partner for TetraScience. By combining our respective strengths, we can empower companies in the therapeutics space to overcome the challenges of leveraging scientific data and accelerating the pace of drug discovery and development."
By releasing the potential of scientific data to drive innovation and enhance patient outcomes, the partnership between PTP and TetraScience is anticipated to have a significant impact on the therapeutics industry. Clients may anticipate receiving the advantages of the combined knowledge and resources of two pioneers in the field, enabling them to confidently negotiate the challenging and quickly changing environment of drug research and development.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
